Literature DB >> 1539986

Novel assay for screening rifamycin B-producing mutants.

R M Vohra1.   

Abstract

A simple method that allows easy identification of rifamycin B-producing strains is described. This method involves the use of an enzyme, rifamycin oxidase, which converts inactive rifamycin B to active rifamycin S. In this method, colonies to be tested are grown in pairs. The two colonies are then transferred to two plates seeded with a sensitive strain of Staphylococcus aureus, one plate of which contains the enzyme rifamycin oxidase. All paired colonies which show a larger inhibition zone diameter on the enzyme-containing plate are identified as rifamycin B producers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1539986      PMCID: PMC195222          DOI: 10.1128/aem.58.1.403-404.1992

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  5 in total

1.  Identification and quantitation of rifamycins by reversed-phase high-performance liquid chromatography.

Authors:  R M Vohra; S Dube
Journal:  J Chromatogr       Date:  1989-08-30

2.  Tuberculosis and leprosy.

Authors: 
Journal:  Br Med Bull       Date:  1988-07       Impact factor: 4.291

3.  Isolation of rifamycin SV from a mutant Streptomyces mediterranei strain.

Authors:  G Lancini; C Hengeller
Journal:  J Antibiot (Tokyo)       Date:  1969-12       Impact factor: 2.649

4.  A brief review of experiences with short-term clinical trials monitored by mouse-foot-pad-inoculation.

Authors:  C C Shepard
Journal:  Lepr Rev       Date:  1981-12       Impact factor: 0.537

5.  New rifamycins produced by a recombinant strain of Nocardia mediterranei.

Authors:  T Schupp; P Traxler; J A Auden
Journal:  J Antibiot (Tokyo)       Date:  1981-08       Impact factor: 2.649

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.